ARTEROLANE MALEATE AND PIPERAQUINE PHOSPHATE: A NEW OPTION IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 3

Abstract

Malaria is holoendemic in India, claiming thousands of deaths annually. Recent data suggests that the burden of malaria, the most significant parasitic disease in the world, is increasing. India’s expansive geography and diverse climate supports ideal environment for sustaining malarial parasites and their vectors. The National Drug Policy of India recommends artemisinin based combination treatment for the management of malaria. Although the use of Artemisinin has strengthened global efforts to combat malaria, multi-drug resistance has increasingly become a major impediment to malaria control. The complete clearance of parasites is dependent on the partner drug in the combination being effective and also persisting at parasiticidal concentrations until most of the infecting parasites have been killed. Arterolane maleate (150mg) and piperaquine phosphate (750mg) combination is a novel antimalarial combination that is not based on artemisinin. This combination provides rapid clearance of parasitemia and malaria-related symptoms, coupled with prevention of recrudescence. Additionally, a short course treatment of 3 days encourages compliance. Combination of arterolane and piperaquine is a safe and well-tolerated drug combination, making it a welcome addition to the armamentarium against Plasmodium falciparum.

Authors and Affiliations

Suruchi Aditya*| Deptt. Of Pharmacology,Dr Harvansh Singh Judge Institute of Dental Sciences, Sector 25,Chandigarh, India-160 014, Ruchika Nandha| Deptt. Of Pharmacology,Dr Harvansh Singh Judge Institute of Dental Sciences, Sector 25,Chandigarh, India-160 014, Kavita Sekhri| President, Tyagi Pharmacy Association & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074, Prof. Satyanand Tyagi

Keywords

Related Articles

ANTIOXIDANT ACTIVITY OF HERBAL PLANTS: A RECENT REVIEW

Antioxidants or inhibitors of oxidation are compounds which retard or prevent the oxidation and in general prolong the life of the oxidizable matter. Majority of the diseases/disorders are mainly linked to oxidative stre...

A Study on Hepatic aminotransferases among elderly hypertensive patients: a population based observation

Objective: To study the relationship of Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) with elderly hypertensive patients. Materials and methods: 95 elderly patients aged between 50 to 75 years of ei...

Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors

EGFR is a significant drug target approached in the domain of the wide prevailing cancer type, non- small cell lung cancer and search for its potent inhibitor is an emerging opportunity in cancer drug discovery. Computat...

Medicated chewing gum: modern approach to improve mucosal drug delivery system- a review

In current years technological advancements have been made in the research and development of oral drug delivery systems. It is considered to be a potential and convenient modified release drug delivery system which can...

CNS AGENTS ON HIV/AIDS: OVERVIEW

HIV/AIDS patients suffering from depression more often treated with various drugs like Methylphenidate, Dextroamphetamine to treat depression and also with psychoactive drugs to treat side effects like insomnia. Sometime...

Download PDF file
  • EP ID EP1363
  • DOI -
  • Views 540
  • Downloads 30

How To Cite

Suruchi Aditya*, Ruchika Nandha, Kavita Sekhri (2013). ARTEROLANE MALEATE AND PIPERAQUINE PHOSPHATE: A NEW OPTION IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA. Journal of Drug Discovery and Therapeutics, 1(3), 66-69. https://www.europub.co.uk/articles/-A-1363